Work

Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype–Guided Dosing

Year: 2020

Type: article

Study design: Clinical Trial

Source: PMC

Authors: Smita S. Joshi, Daniel V.T. Catenacci, Theodore Karrison, Jaclyn D Peterson, Mark M. Zalupski, Amikar Sehdev, James L. Wade, Ahad A. Sadiq, Vincent J. Picozzi, Andrea Amico, Robert de Wilton Marsh, Mark Kozloff, Blasé N. Polite, Hedy L. Kindler, Manish Sharma

Institutions: University of Chicago, University of Michigan, Indiana University Indianapolis, Decatur Memorial Hospital, Fort Wayne Medical Institute, Virginia Mason Medical Center, Silver Cross Hospital, University of Chicago Medicine Comprehensive Cancer Center, Endeavor Health, Ingalls Memorial Hospital, University of Chicago Medical Center

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3135306748

FWCI:

Cites:

Cited by:

Related to: 10